Sign in

CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Alto Neuroscience, Inc.

Sign in to watch
Ticker
ANRO
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
834210124
Phone
773-255-5012
Business address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
  1. 8-K Event Results of operations
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 8-K Event Other events
  5. SC 13G Stake Amended Statement of Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  9. 4 Open-market buy CHIEF MEDICAL OFFICER bought 15,000 shares at an average $12.72 ($190,833)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 6,150 shares at an average $16.36 ($100,628)
  16. SC 13G Stake Amended Statement of Ownership
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 7 of 10 · 198 filings